ProShare Advisors LLC - SIENNA BIOPHARMACEUTICALS IN ownership

SIENNA BIOPHARMACEUTICALS IN's ticker is SNNAQ and the CUSIP is 82622H108. A total of 61 filers reported holding SIENNA BIOPHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of SIENNA BIOPHARMACEUTICALS IN
ValueSharesWeighting
Q3 2018$154,000
-5.5%
10,367
-3.5%
0.00%0.0%
Q2 2018$163,000
-24.2%
10,743
-6.0%
0.00%0.0%
Q1 2018$215,000
+0.5%
11,426
-3.3%
0.00%0.0%
Q4 2017$214,00011,8130.00%
Other shareholders
SIENNA BIOPHARMACEUTICALS IN shareholders Q4 2018
NameSharesValueWeighting ↓
Golden State Wealth Management, LLC 180,552$36,0000.01%
MILLENNIUM MANAGEMENT LLC 122,942$24,0000.00%
CITIGROUP INC 1,739$00.00%
GOLDMAN SACHS GROUP INC 52,553$11,0000.00%
MORGAN STANLEY 101$00.00%
ACADIAN ASSET MANAGEMENT LLC 15,936$3,0000.00%
BANK OF MONTREAL /CAN/ 20$00.00%
BlackRock Inc. 90,036$18,0000.00%
Ballentine Partners, LLC 16,700$3,0000.00%
Citadel Advisors 83,839$17,0000.00%
View complete list of SIENNA BIOPHARMACEUTICALS IN shareholders